Top outbound deal value in pharmaceutical sector in India 2017-2023, by company
In 2022, Biocon Biologics acquired Viatris with a value of over three billion U.S. dollars, contributing the largest share in the outbound deals. In comparison, Sun Pharma acquired Concert Pharma and Taro Pharmaceuticals with a deal value of 569 and 307 million U.S. dollars each in 2023.